Amarin corporation plc

Major-Pharmaceuticals

AMRN


2 Pembroke House
Dublin , 2

Executive/
Director

Price

  • Last Close
  • $ 0.53
    $ +0 0.76 %
    Jan 3, 2025
  • 52-Week High/Low
  • $1.35 - $0.61
  • YTD
  • 9.3%

  • Trading Volume
  • 4,544
  • Market Cap Full
  • $ 201.8K
  • Shares Outstanding
  • 0.4M
    Feb 20, 2013
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 -19.1% 3.9% -24.9% 52.5% -5% 25.9% -2.2% 24% 3.5% 9.3%
Q2 41.2% 25.9% 5.8% -5% 4% -29.5% -54.8% -20.7% -19.9% -
Q3 47.7% -13.2% 453.4% -24.4% 8% 16.4% -26.9% -22.7% -7.6% -
Q4 -3.5% 14.9% -15.1% 43.6% 17.1% -33.9% 11% 2.7% -4% -
J F M A M J J A S O N D
2025 9.3% - - - - - - - - - - -
2024 29.9% -5.3% -15.9% -3% -0.3% -17.9% -4.5% -7.6% - - - -
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    93%63%30%239%56%-77%-32%-64%-28%-44%9%

Earnings

2016 2017 2018 2019 2020 2021 2022 2023
Q1 0.15 0.08 -0.08 -0.07 -0.06 - -0.08 -0.04
Q2 0.11 0.05 -0.12 -0.01 0.01 0.02 -0.18 -0.04
Q3 0.10 0.04 -0.08 -0.01 -0.02 -0.03 -0.01 -0.05
Q4 0.05 0.08 -0.11 0.02 0.02 0.03 0.01 -
A 0.4 0.3 -0.4 -0.1 -0.1 0 -0.3 -0.13

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

Mar
Jun
Sep
Dec

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover 0.6 0.5 0.7 1.3 1
Fixed Asset Turnover 184.5 16.2 9.6 143.3 -
Total Asset Turnover 0.4 0.6 0.6 0.5 0.6
Leverage
Debt Ratio - - - - 0.1
Debt – Equity Ratio - - - - 0.3
Interest Coverage - 3.7 10 24 -13.5
Equity multiplier - 0.1 0.1 - -